Article Information
History
- June 27, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Batel Blechter1,*,†,
- Xiaoyu Wang1,2,†,
- Jianxin Shi1,†,
- Kouya Shiraishi3,†,
- Jiyeon Choi1,†,
- Keitaro Matsuo4,†,
- Tzu-Yu Chen5,6,†,
- Juncheng Dai7,8,†,
- Rayjean J Hung9,†,
- Kexin Chen10,†,
- Xiao-Ou Shu11,†,
- Young Tae Kim12,13,
- Parichoy Pal Choudhury14,
- Jacob Williams1,
- Maria Teresa Landi1,
- Dongxin Lin15,
- Wei Zheng11,
- Zhihua Yin16,
- Bao Song17,
- I-Shou Chang18,
- Yun-Chul Hong19,
- Never Smoker Lung Cancer Working Group,
- Nilanjan ChaVerjee20,21,‡,
- Olga Y Gorlova22,23,‡,
- Christopher I Amos22,23,‡,
- Hongbing Shen7,8,‡,
- Chao Agnes Hsiung5,‡,
- Stephen J Chanock1,‡,
- Nathaniel Rothman1,‡,
- Takashi Kohno3,‡,
- Qing Lan1,*,‡ and
- Haoyu Zhang1,*,‡
- 1Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA
- 2Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc, Rockville, MD, USA
- 3Division of Genome Biology, National Cancer Research Institute, Tokyo, Japan
- 4Division of Molecular Medicine, Aichi Cancer Center Research Institute, Nagoya, Japan
- 5Institute of Population Health Sciences, National Health Research Institutes, Zhunan, Taiwan
- 6Department of Applied Mathematics, Tunghai University, Taichung, Taiwan
- 7Department of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing, China
- 8Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Medicine, Nanjing Medical University, Nanjing, China
- 9Prosserman Centre for Population Health Research, Lunenfeld-Tanenbaum Research Institute, Sinai Health, Toronto, Canada
- 10Department of Epidemiology and Biostatistics, National Clinical Research Center for Cancer, Key Laboratory of Molecular Cancer Epidemiology of Tianjin, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Tianjin, China
- 11Division of Epidemiology, Department of Medicine, Vanderbilt University Medical Center and Vanderbilt-Ingram Cancer Center, Nashville, TN, USA
- 12Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea
- 13Cancer Research Institute, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Republic of Korea
- 14American Cancer Society, Atlanta, GA, USA
- 15Department of Etiology & Carcinogenesis and State Key Laboratory of Molecular Oncology, Cancer Institute and Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
- 16Department of Epidemiology, School of Public Health, China Medical University, Shenyang, China
- 17Department of Oncology, Shandong Cancer Hospital and Institute, Shandong Academy of Medical Sciences, Jinan, China
- 18National Institute of Cancer Research, National Health Research Institutes, Zhunan, Taiwan
- 19Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea
- 20Department of Oncology, School of Medicine, Johns Hopkins University, Baltimore, MD, USA
- 21Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
- 22Department of Medicine, Section of Epidemiology and Population Science, Institute for Clinical and Translational Research, Houston, TX, USA
- 23Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA
- ↵*Correspondence to: Batel Blechter (batel.blechter{at}nih.gov), Qing Lan (qingl{at}mail.nih.gov), and Haoyu Zhang (haoyu.zhang2{at}nih.gov)
↵† These authors contributed equally to this work
Posted June 27, 2024.
Stratifying Lung Adenocarcinoma Risk with Multi-ancestry Polygenic Risk Scores in East Asian Never-Smokers
